{
    "2020-06-08": [
        [
            {
                "time": "2018-01-02",
                "original_text": "AbbVie (ABBV) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Gains",
                        "Lags",
                        "Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Vertex CEO Provided Best Value for Investors",
                "features": {
                    "keywords": [
                        "Vertex",
                        "CEO",
                        "Value",
                        "Investors"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Merck's Antibiotic Recarbrio Gets FDA Nod for New Indication",
                "features": {
                    "keywords": [
                        "Merck",
                        "Antibiotic",
                        "Recarbrio",
                        "FDA",
                        "Nod",
                        "Indication"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie (ABBV) Joins Race for Developing Coronavirus Treatment",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Race",
                        "Coronavirus",
                        "Treatment"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Silgan, Canada Goose, Sempra Energy, Fortinet and Abbvie highlighted as Zacks Bull and Bear of the Day",
                "features": {
                    "keywords": [
                        "Silgan",
                        "Canada Goose",
                        "Sempra Energy",
                        "Fortinet",
                        "Abbvie",
                        "Zacks",
                        "Bull",
                        "Bear"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diverse sectors"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie’s Rinvoq Beats Bristol-Myers’ Orencia In New Rheumatoid Arthritis Data",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rinvoq",
                        "Bristol-Myers",
                        "Orencia",
                        "Rheumatoid",
                        "Arthritis",
                        "Data"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}